Pre-existing immunity does not impair the engraftment of CRISPR-Cas9-edited cells in rhesus macaques conditioned with busulfan or radiation-Reference-Cited by-同舟云学术

Pre-existing immunity does not impair the engraftment of CRISPR-Cas9-edited cells in rhesus macaques conditioned with busulfan or radiation

Published:2023-06 Issue: Volume:29 Page:483-493
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Essawi Khaled,Hakami Waleed,Naeem Khan Muhammad Behroz,Martin Reid,Zeng Jing,Chu Rebecca,Uchida Naoya,Bonifacino Aylin C.,Krouse Allen E.,Linde Nathaniel S.,Donahue Robert E.,Blobel Gerd A.,Gerdemann Ulrike,Kean Leslie S.,Maitland Stacy A.,Wolfe Scot A.,Metais Jean-Yves,Gottschalk Stephen,Bauer Daniel E.,Tisdale John F.,Demirci Selami^ORCID

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference46 articles.

1. Multiplex genome engineering using CRISPR/Cas systems;Cong;Science,2013

2. RNA-guided human genome engineering via Cas9;Mali;Science,2013

3. Therapeutic genome editing: prospects and challenges;Cox;Nat. Med.,2015

4. CRISPR/Cas9 for sickle cell disease: applications, future possibilities, and challenges;Demirci;Adv. Exp. Med. Biol.,2019

5. Genome editing strategies for fetal hemoglobin induction in beta-hemoglobinopathies;Demirci;Hum. Mol. Genet.,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPR/Cas9 Landscape: Current State and Future Perspectives;International Journal of Molecular Sciences;2023-11-08

2. Efficient manufacturing and engraftment of CCR5 gene-edited HSPCs following busulfan conditioning in nonhuman primates;Molecular Therapy - Methods & Clinical Development;2023-09